Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer that has not spread to other parts of the body (non-metastatic)
- People who are willing and able to follow all the steps and procedures required by the study
- People who have read, understood, and signed the consent form before joining
- People who are covered by the social security system
- People who are able to sit for 1.5-hour sessions during the study
Who may not be able to join:
- People whose cancer has spread to other parts of the body (metastatic cancer)
- People currently experiencing an acute (active and severe) psychiatric condition, such as severe depression, unstable bipolar disorder, or a psychotic disorder involving delusions or hallucinations
- People who experience frequent, uncontrolled panic attacks, particularly those linked to strong health-related fears or anxiety
- People who have significant difficulties with attention, memory, or thinking that may make participating in meditation difficult
- People who have cognitive or neurological conditions that affect memory or thinking ability
- People who are deaf
- People who are currently taking part in another mindfulness program
- People who are under legal guardianship, curatorship, or are otherwise deprived of their liberty
- People for whom regular medical check-ins as part of the trial would not be possible due to geographic location, social circumstances, or psychological reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: François Bourgognon, MD, Institut de Cancérologie de Lorraine
Phone: +33 3 83 59 84 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Demonstrate the efficacy of the MAEva program versus discussion group on quality of life in patients with non-metastatic breast cancer.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.